Zobrazeno 1 - 10
of 308
pro vyhledávání: '"TAKAO TAMURA"'
Autor:
Hiromichi Nakajima, Shota Fukuoka, Toshiki Masuishi, Atsuo Takashima, Yosuke Kumekawa, Takeshi Kajiwara, Kentaro Yamazaki, Yuji Negoro, Masato Komoda, Akitaka Makiyama, Tadamichi Denda, Yukimasa Hatachi, Takeshi Suto, Naotoshi Sugimoto, Masanobu Enomoto, Toshiaki Ishikawa, Tomomi Kashiwada, Koji Ando, Satoshi Yuki, Hiroyuki Okuyama, Hitoshi Kusaba, Daisuke Sakai, Koichi Okamoto, Takao Tamura, Kimihiro Yamashita, Masahiko Gosho, Toshikazu Moriwaki
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPrimary tumor location (PTL) is an important prognostic and predictive factor in the first-line treatment of metastatic colorectal cancer (mCRC). Although regorafenib (REG) and trifluridine/tipiracil (FTD/TPI) have been introduced recently,
Externí odkaz:
https://doaj.org/article/1b5c529d863847208161fdacda20bb31
Autor:
Keigo Chida, Daisuke Kotani, Toshikazu Moriwaki, Shota Fukuoka, Toshiki Masuishi, Atsuo Takashima, Yosuke Kumekawa, Takeshi Kajiwara, Kentaro Yamazaki, Masato Komoda, Akitaka Makiyama, Tadamichi Denda, Yukimasa Hatachi, Takeshi Suto, Naotoshi Sugimoto, Masanobu Enomoto, Toshiaki Ishikawa, Tomomi Kashiwada, Koji Ando, Satoshi Yuki, Yoshihiro Okita, Hitoshi Kusaba, Daisuke Sakai, Koichi Okamoto, Takao Tamura, Kimihiro Yamashita, Masahiko Gosho, Yasuhiro Shimada
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Background: The survival benefits of regorafenib (REG) and trifluridine/tipiracil hydrochloride (TFTD) have been demonstrated in chemorefractory patients with metastatic colorectal cancer (mCRC). However, the effects of crossover administration of RE
Externí odkaz:
https://doaj.org/article/62fbb44c692c4df88be7192d21a1ba7b
Publikováno v:
International Journal of Medical Sciences, Vol 9, Iss 6, Pp 441-446 (2012)
Objective: Adverse event reports (AERs) submitted to the US Food and Drug Administration (FDA) were reviewed to assess the bleeding complications induced by the administration of antiplatelets and to attempt to determine the rank-order of the associa
Externí odkaz:
https://doaj.org/article/3e0538bbd91d4a31b16ba489081c480d
Publikováno v:
International Journal of Medical Sciences, Vol 9, Iss 10, Pp 833-837 (2012)
Background: Reports have been accumulating that genetic properties are predictive of clinical response after and/or toxicity during cancer chemotherapy, but little information is available concerning effects on long-term survival. In this study, 49 J
Externí odkaz:
https://doaj.org/article/6669754a482c4ab4abd2c74fa5208faf
Publikováno v:
International Journal of Medical Sciences, Vol 9, Iss 5, Pp 322-326 (2012)
Objective: Case reports showing that proton-pump inhibitors (PPIs), omeprazole and esomeprazole, can cause hypomagnesaemia have been accumulating since 2006. In this study, the reports submitted to the Adverse Event Reporting System (AERS) of the US
Externí odkaz:
https://doaj.org/article/554bdb2d3d994b11a11004eba29f60a9
Publikováno v:
International Journal of Medical Sciences, Vol 8, Iss 5, Pp 406-412 (2011)
Objectives: The irinotecan (CPT-11) + 5-fluorouracil (5-FU)/leucovorin (LV) + UFT/LV chemotherapy, in which repetitive oral administration of UFT/LV replaces the infusion of 5-FU/LV in the FOLFIRI regimen, has been proposed previously. In this study,
Externí odkaz:
https://doaj.org/article/ea0629fb1f25465e8163f11017adb665
Autor:
Kimio Yonesaka, Naoki Takegawa, Taroh Satoh, Hiroto Ueda, Takeshi Yoshida, Masayuki Takeda, Toshio Shimizu, Yasutaka Chiba, Isamu Okamoto, Kazuto Nishio, Takao Tamura, Kazuhiko Nakagawa
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0143132 (2015)
Amphiregulin, a ligand of the epidermal growth factor receptor (EGFR), is associated with the efficacy of cetuximab, an antibody against EGFR, as treatment for colorectal cancer (CRC). In contrast, the HER3 ligand heregulin correlates with cetuximab
Externí odkaz:
https://doaj.org/article/253da84506574115b17488155511da57
Autor:
Kazuko Sakai, Junji Tsurutani, Takeharu Yamanaka, Azusa Yoneshige, Akihiko Ito, Yosuke Togashi, Marco A De Velasco, Masato Terashima, Yoshihiko Fujita, Shuta Tomida, Takao Tamura, Kazuhiko Nakagawa, Kazuto Nishio
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0121891 (2015)
Somatic mutations in KRAS, NRAS, and BRAF genes are related to resistance to anti-EGFR antibodies in colorectal cancer. We have established an extended RAS and BRAF mutation assay using a next-generation sequencer to analyze these mutations. Multiple
Externí odkaz:
https://doaj.org/article/19f7edc251154a5fb2fabc94f36b8b4b
Autor:
Yasuhiro Kidera, Hisato Kawakami, Tsutomu Sakiyama, Kunio Okamoto, Kaoru Tanaka, Masayuki Takeda, Hiroyasu Kaneda, Shin-ichi Nishina, Junji Tsurutani, Kimiko Fujiwara, Morihiro Nomura, Yuzuru Yamazoe, Yasutaka Chiba, Shozo Nishida, Takao Tamura, Kazuhiko Nakagawa
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101902 (2014)
Nephrotoxicity remains a problem for patients who receive cisplatin chemotherapy. We retrospectively evaluated potential risk factors for cisplatin-induced nephrotoxicity as well as the potential impact of intravenous magnesium supplementation on suc
Externí odkaz:
https://doaj.org/article/2127ad550f014310826f2ead74b7747e
Autor:
Masahiko Aoki, Shigenori Kadowaki, Naoki Takahashi, Takeshi Suzuki, Kotoe Oshima, Takayuki Ando, Yoshiyuki Yamamoto, Kentaro Kawakami, Yosuke Kito, Toshihiko Matsumoto, Keitaro Shimozaki, Yasuhiro Miyazaki, Toshifumi Yamaguchi, Michitaka Nagase, Takao Tamura, Yusuke Amanuma, Taito Esaki, Yuji Miura, Kohei Akiyoshi, Eishi Baba, Akitaka Makiyama, Yuji Negoro, Koji Nakashima, Naotoshi Sugimoto, Kengo Nagashima, Hirokazu Shoji, Narikazu Boku
Publikováno v:
Gastric Cancer. 26:132-144
Background Accelerated tumor growth during immunotherapy in pre-existing measurable lesions, hyperprogressive disease (HPD), has been reported. However, progression of non-measurable lesions and new lesions are frequently observed in patients with ad